Ubs Asset Management Americas Inc Amgen Inc Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Amgen Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 5,282,439 shares of AMGN stock, worth $1.45 Billion. This represents 0.31% of its overall portfolio holdings.
Number of Shares
5,282,439
Previous 4,652,342
13.54%
Holding current value
$1.45 Billion
Previous $1.45 Billion
1.76%
% of portfolio
0.31%
Previous 0.38%
Shares
30 transactions
Others Institutions Holding AMGN
# of Institutions
3,275Shares Held
442MCall Options Held
6.15MPut Options Held
7.25M-
Vanguard Group Inc Valley Forge, PA53.7MShares$14.8 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.6 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.06 Billion0.32% of portfolio
-
Capital International Investors Los Angeles, CA18.9MShares$5.19 Billion0.95% of portfolio
-
Capital World Investors Los Angeles, CA16.9MShares$4.63 Billion0.71% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $147B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...